Psychedelic drugs for the treatment of substance use disorders.
Expert Review of Clinical Pharmacology July 29, 2025 DOI: 10.1080/17512433.2025.2541103 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Addiction |
Abstract
1. Substance Use Disorder (SUD) continues to have a growing global impact, affecting an estimated 64 million individuals worldwide [1]. While pharmacotherapies are available for opioid, tobacco, an...
Citations in the library
Cites 12
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
- Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey Journal of Psychoactive Drugs August 19, 2021
- Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial EClinicalMedicine March 14, 2025
- The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews May 1, 2025
- Predictors of Psychedelic Experience: A Thematic Analysis Journal of Psychoactive Drugs October 5, 2022
and 7 more in the library